304 related articles for article (PubMed ID: 30126643)
1. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.
Vihta KD; Stoesser N; Llewelyn MJ; Quan TP; Davies T; Fawcett NJ; Dunn L; Jeffery K; Butler CC; Hayward G; Andersson M; Morgan M; Oakley S; Mason A; Hopkins S; Wyllie DH; Crook DW; Wilcox MH; Johnson AP; Peto TEA; Walker AS
Lancet Infect Dis; 2018 Oct; 18(10):1138-1149. PubMed ID: 30126643
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis.
Bryce A; Hay AD; Lane IF; Thornton HV; Wootton M; Costelloe C
BMJ; 2016 Mar; 352():i939. PubMed ID: 26980184
[TBL] [Abstract][Full Text] [Related]
3. Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011.
Schlackow I; Stoesser N; Walker AS; Crook DW; Peto TE; Wyllie DH;
J Antimicrob Chemother; 2012 Jun; 67(6):1514-24. PubMed ID: 22438437
[TBL] [Abstract][Full Text] [Related]
4. Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013-18): a quasi-experimental, ecological, data linkage study.
Aliabadi S; Anyanwu P; Beech E; Jauneikaite E; Wilson P; Hope R; Majeed A; Muller-Pebody B; Costelloe C
Lancet Infect Dis; 2021 Dec; 21(12):1689-1700. PubMed ID: 34363774
[TBL] [Abstract][Full Text] [Related]
5. An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn R; McDermott TE; Murphy P; Grainger R; Fennell JP; Thornhill JA
Ir J Med Sci; 2013 Mar; 182(1):81-9. PubMed ID: 22669684
[TBL] [Abstract][Full Text] [Related]
6. Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection.
Leflon-Guibout V; Ternat G; Heym B; Nicolas-Chanoine MH
J Antimicrob Chemother; 2002 Feb; 49(2):367-71. PubMed ID: 11815581
[TBL] [Abstract][Full Text] [Related]
7. Co-Amoxiclav as empiric treatment of UTI in children: importance of surveillance in ensuring optimal empiric treatment choice.
Trayer J; Horgan M; Prior AR; Ryan M; Nadeem M
Int J Clin Pharm; 2022 Feb; 44(1):256-259. PubMed ID: 34423380
[TBL] [Abstract][Full Text] [Related]
8. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
[TBL] [Abstract][Full Text] [Related]
10. E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community.
McCowan C; Bakhshi A; McConnachie A; Malcolm W; Barry SJ; Santiago VH; Leanord A
BMC Infect Dis; 2022 Oct; 22(1):805. PubMed ID: 36307776
[TBL] [Abstract][Full Text] [Related]
11. Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK.
Lipworth S; Vihta KD; Chau K; Barker L; George S; Kavanagh J; Davies T; Vaughan A; Andersson M; Jeffery K; Oakley S; Morgan M; Hopkins S; Peto TEA; Crook DW; Walker AS; Stoesser N
Genome Med; 2021 Sep; 13(1):144. PubMed ID: 34479643
[TBL] [Abstract][Full Text] [Related]
12. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ
Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
Meier S; Weber R; Zbinden R; Ruef C; Hasse B
Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
[TBL] [Abstract][Full Text] [Related]
14. No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia.
Wei J; Uppal A; Nganjimi C; Warr H; Ibrahim Y; Gu Q; Yuan H; Rahman NM; Jones N; Walker AS; Eyre DW
J Infect; 2024 Jun; 88(6):106161. PubMed ID: 38663754
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance associations with national primary care antibiotic stewardship policy: Primary care-based, multilevel analytic study.
Hammond A; Stuijfzand B; Avison MB; Hay AD
PLoS One; 2020; 15(5):e0232903. PubMed ID: 32407346
[TBL] [Abstract][Full Text] [Related]
16. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
Lishman H; Costelloe C; Hopkins S; Johnson AP; Hope R; Guy R; Muller-Pebody B; Holmes A; Aylin P
Int J Antimicrob Agents; 2018 Dec; 52(6):790-798. PubMed ID: 30145249
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment failure of uncomplicated urinary tract infections in primary care.
Koh SWC; Ng TSM; Loh VWK; Goh JC; Low SH; Tan WZ; Wong HC; Durai P; Sun LJ; Young D; Tambyah PA
Antimicrob Resist Infect Control; 2023 Aug; 12(1):73. PubMed ID: 37528415
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
[TBL] [Abstract][Full Text] [Related]
19. Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London.
Blandy O; Honeyford K; Gharbi M; Thomas A; Ramzan F; Ellington MJ; Hope R; Holmes AH; Johnson AP; Aylin P; Woodford N; Sriskandan S
J Hosp Infect; 2019 Feb; 101(2):120-128. PubMed ID: 30403958
[TBL] [Abstract][Full Text] [Related]
20. Empiric antibiotic treatment for urinary tract infection in preschool children: susceptibilities of urine sample isolates.
Butler CC; O'Brien K; Wootton M; Pickles T; Hood K; Howe R; Waldron CA; Thomas-Jones E; Dudley J; Van Der Voort J; Rumsby K; Little P; Downing H; Harman K; Hay AD;
Fam Pract; 2016 Apr; 33(2):127-32. PubMed ID: 26984993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
